Hyperfuel Dec 2024 a Series of CGF2021 LLC (CIK: 0002053615) EDGAR, Information, Filings... CompaniesBIO.Com

Hyperfuel Dec 2024 a Series of CGF2021 LLC

Mailing address
2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703
Phone
(360) 946-0604
State location
Delaware
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Hyperfuel Dec 2024 a Series of CGF2021 LLC (CIK: 0002053615) is an American company incorporated in the state of Delaware. Head office is located at 2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703. Work in the industry N/A. Hyperfuel Dec 2024 a Series of CGF2021 LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Hyperfuel Dec 2024 a Series of CGF2021 LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002053615-25-000001 (33 Act) Size: KB	Jan-29-2025	021-536616 25566839

Recent 20 filings. View all Hyperfuel Dec 2024 a Series of CGF2021 LLC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Hyperfuel Dec 2024 a Series of CGF2021 LLC overview
Hyperfuel Dec 2024 a Series of CGF2021 LLC job
Hyperfuel Dec 2024 a Series of CGF2021 LLC stock
Hyperfuel Dec 2024 a Series of CGF2021 LLC ownership
Hyperfuel Dec 2024 a Series of CGF2021 LLC CEO
Hyperfuel Dec 2024 a Series of CGF2021 LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.